Industry veteran Sri Kosaraju joins the Board of Nevro

Sri Kosaraju

Nevro Corp., a global medical device company that provides innovative, evidence-based solutions for the treatment of chronic pain, announced that Sri Kosaraju has been appointed as a member of the Board of Directors, effective August 31, 2021.

“We are delighted to have Sri join our Board of Directors,” said D. Keith Grossman, Chairman, President and CEO of Nevro. “Sri’s significant experience in leading high-growth life science and medical technology companies as well as his deep background in the healthcare industry will make him a valuable addition to our board.  We look forward to Sri’s contributions to our Board of Directors and the continuing success of Nevro.”

“I’m excited to be joining Nevro’s Board,” said Kosaraju. “I have high respect for Keith and his leadership.  Furthermore, I look forward to working with this world-class Board to support the Nevro team as it pursues impactful products for patients and continues to develop attractive long-term growth opportunities for its stakeholders.”

Kosaraju currently serves as the Chief Executive Officer and President of Inscripta, Inc., the digital genome engineering company, a position he has held since October 2020. Prior to joining Inscripta, Kosaraju was President of Penumbra, Inc., which he joined as CFO in May 2015. 

Earlier, Kosaraju spent 16 years at J.P. Morgan, where he was most recently Head of Healthcare Equity Capital Markets and Co-Head of Technology Equity Capital Markets. While at J.P. Morgan, he worked closely with and advised many emerging, high-growth life science and tech companies. In addition to serving on the Board of Directors for Inscripta, Kosaraju also currently serves on the Board of Directors and is the Chair of the Audit Committee of 10x Genomics, Inc. and is on the Board of the non-profit Testing for America. 

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain.

+ posts

HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.

What's your take on this post ? Comment: